Science News Roundup August 12, 2016Posted by stuffilikenet in Awesome, Brain, Geek Stuff, Science, Star Trek Technology, Uncategorizable.
I haven’t had a lot of free time for stuff I like lately, but I didn’t want a few items from my science newsfeeds to go unnoticed by you, my adoring public. I expect most people don’t follow this kind of stuff closely, so pay attention:
First off, a team from the UK has found that a commonly available drug Fenamate can reduce the inflammation in a particular pathway to protect against a Alzheimer’s disease model in rodents. A mouse is not a man, but the results are intriguing enough (protected all rats in the study) that trials with humans are being strongly considered. Because the drug is already approved for pain relief, the difficulty in getting into trials in the first place is enormously reduced. “In the USA, wholesale price of a week’s supply of generic mefenamic acid has been quoted as $426.90 in 2014. Brand-name Ponstel is $571.70. In contrast, in the UK, a weeks supply is £1.66, or £8.17 for branded Ponstan. In the Philippines, 10 tablets of 500 mg generic mefenamic acid cost PHP39.00 (or the equivalent of $0.88USD) as of October 25, 2014.”—Wikipedia.
Evil bastards? Well, sure. What do you expect from companies who can buy or sell legislators?
Next, paraplegic patients have had nerve and muscle function partially restored using a three-step training regimen in Brazil. Starting with VR to give them the sensation of walking through haptic feedback during brain-controlled maneuvering through a VR landscape, the patients then proceeded to move using a robotic walker on a treadmill with full support, also run through the brain-machine interface. Finally, they practiced walking with the robosuit used in that World Cup game a couple of years ago. This took months, but the eight fully paralyzed patients who completed (one moved away) ALL showed some improvement.
This is a big deal. None of these guys were ever supposed to get any sensation or control back.
This program is on-going, so we don’t know how much improvement will ultimately result from this innovative program, but I for one am pretty excited. Isn’t this why we work in computer science in the first place?